The new frontiers of supply chain disruption – and how pharma firms are responding
While supply chain issues are a constant for the pharma industry, the Coronavirus global pandemic sent shockwaves through the sector,…
While supply chain issues are a constant for the pharma industry, the Coronavirus global pandemic sent shockwaves through the sector,…
This issue is driven by several factors, including the high cost of proprietary medications, the increasing use of the internet…
Any metal contamination in pharmaceutical products is a huge problem. First and foremost, there are possible safety implications for patients…
The expansion at Macungie will offer increased capacity for secondary packaging activities including Vial Labeling, Pre-Filled Syringe (PFS) assembly and labeling, Autoinjector/Pen assembly…
As clinical trials become more complex, the use of electronic clinical outcome assessments (eCOAs) is increasingly important for collecting and…
Epilepsy is a chronic neurological condition characterised by recurring seizures, involuntary movements affecting the body. Idiopathic generalised epilepsy is the…
According to GlobalData, the keyword ‘emissions’ was mentioned 6,272 times across the company filings of pharma organizations in 2023 –…
Recent trends highlight a surge in demand for mass market medicines. This increase is driven by lessons from the Covid-19…
Drug shortages worldwide are worsening due to increased demand for high-quality manufacturing capacity in the pharmaceutical industry. Short-term contingency plans…
Manufacturing capacity, safety and increasing costs are among the main concerns for drug manufacturers and CMOs. These crucial elements are…